Global OTC and DTC Infectious Disease Diagnostic Market Research Report 2026(Status and Outlook)
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirementsThe global OTC (Over-the-Counter) and DTC (Direct-to-Consumer) infectious disease diagnostic market refers to the market for diagnostic tests that can be purchased without a prescription or directly by consumers for the detection of infectious diseases. These diagnostic tests are designed to be user-friendly, affordable, and accessible, allowing individuals to self-diagnose and monitor their health conveniently at home.Here are some key factors influencing the growth of the global OTC and DTC infectious disease diagnostic market:Increasing consumer awareness and demand: Over the years, there has been a significant increase in consumer awareness regarding infectious diseases and the importance of early detection. Individuals are seeking convenience and control over their healthcare, leading to a growing demand for OTC and DTC diagnostic tests. These tests allow individuals to quickly and easily screen for infectious diseases from the comfort of their homes, without the need for a doctor?s visit.Advancements in technology: Technological advancements have paved the way for the development of accurate and reliable OTC and DTC diagnostic tests for infectious diseases. Rapid diagnostic tests, including lateral flow immunoassays and molecular-based tests, have become more sensitive, specific, and user-friendly. The integration of digital health technologies, such as smartphone apps and connectivity options, further enhances the usability and accessibility of these tests.COVID-19 pandemic: The ongoing COVID-19 pandemic has significantly accelerated the adoption of OTC and DTC infectious disease diagnostic tests. The need for widespread testing, contact tracing, and monitoring of COVID-19 cases has created a demand for accessible and affordable testing options. The availability of COVID-19 self-testing kits and at-home PCR testing has showcased the potential of OTC and DTC testing, driving awareness and acceptance among consumers.Regulatory landscape: Regulatory agencies have played a crucial role in shaping the OTC and DTC infectious disease diagnostic market. Clear guidelines and regulatory frameworks for the development, marketing, and sale of these tests ensure their safety, accuracy, and performance. Regulatory approvals and certifications provide assurance to consumers, paving the way for increased adoption of these tests.Market players and collaborations: Various companies and startups are actively investing in the development and commercialization of OTC and DTC infectious disease diagnostic tests. These companies collaborate with technology providers, pharmaceutical companies, and telehealth platforms to expand their product offerings and reach a wider consumer base. Partnerships with retail pharmacies, e-commerce platforms, and telemedicine providers also facilitate the distribution and accessibility of these tests.The global OTC and DTC infectious disease diagnostic market can be segmented based on disease type, test type, end-user, and geography. Disease types may include respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Test types can include rapid antigen tests, molecular tests, serological tests, and others. End-users may include households, pharmacies, online retailers, and others.Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market dynamics and consumer preferences may vary across these regions.In summary, the global OTC and DTC infectious disease diagnostic market is driven by increasing consumer awareness, technological advancements, the impact of the COVID-19 pandemic, regulatory landscape, and collaborations among market players. The market is expected to witness significant growth as more individuals seek accessible and convenient options for self-diagnosis and monitoring of infectious diseases.The global OTC (Over-the-Counter) and DTC (Direct-to-Consumer) infectious disease diagnostic market refers to the market for diagnostic tests that can be purchased without a prescription or directly by consumers for the detection of infectious diseases. These diagnostic tests are designed to be user-friendly, affordable, and accessible, allowing individuals to self-diagnose and monitor their health conveniently at home.Here are some key factors influencing the growth of the global OTC and DTC infectious disease diagnostic market:Increasing consumer awareness and demand: Over the years, there has been a significant increase in consumer awareness regarding infectious diseases and the importance of early detection. Individuals are seeking convenience and control over their healthcare, leading to a growing demand for OTC and DTC diagnostic tests. These tests allow individuals to quickly and easily screen for infectious diseases from the comfort of their homes, without the need for a doctor?s visit.Advancements in technology: Technological advancements have paved the way for the development of accurate and reliable OTC and DTC diagnostic tests for infectious diseases. Rapid diagnostic tests, including lateral flow immunoassays and molecular-based tests, have become more sensitive, specific, and user-friendly. The integration of digital health technologies, such as smartphone apps and connectivity options, further enhances the usability and accessibility of these tests.COVID-19 pandemic: The ongoing COVID-19 pandemic has significantly accelerated the adoption of OTC and DTC infectious disease diagnostic tests. The need for widespread testing, contact tracing, and monitoring of COVID-19 cases has created a demand for accessible and affordable testing options. The availability of COVID-19 self-testing kits and at-home PCR testing has showcased the potential of OTC and DTC testing, driving awareness and acceptance among consumers.Regulatory landscape: Regulatory agencies have played a crucial role in shaping the OTC and DTC infectious disease diagnostic market. Clear guidelines and regulatory frameworks for the development, marketing, and sale of these tests ensure their safety, accuracy, and performance. Regulatory approvals and certifications provide assurance to consumers, paving the way for increased adoption of these tests.Market players and collaborations: Various companies and startups are actively investing in the development and commercialization of OTC and DTC infectious disease diagnostic tests. These companies collaborate with technology providers, pharmaceutical companies, and telehealth platforms to expand their product offerings and reach a wider consumer base. Partnerships with retail pharmacies, e-commerce platforms, and telemedicine providers also facilitate the distribution and accessibility of these tests.The global OTC and DTC infectious disease diagnostic market can be segmented based on disease type, test type, end-user, and geography. Disease types may include respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Test types can include rapid antigen tests, molecular tests, serological tests, and others. End-users may include households, pharmacies, online retailers, and others.Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market dynamics and consumer preferences may vary across these regions.In summary, the global OTC and DTC infectious disease diagnostic market is driven by increasing consumer awareness, technological advancements, the impact of the COVID-19 pandemic, regulatory landscape, and collaborations among market players. The market is expected to witness significant growth as more individuals seek accessible and convenient options for self-diagnosis and monitoring of infectious diseases.
The global OTC and DTC Infectious Disease Diagnostic market size was estimated at USD 5438.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global OTC and DTC Infectious Disease Diagnostic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global OTC and DTC Infectious Disease Diagnostic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the OTC and DTC Infectious Disease Diagnostic market.
Global OTC and DTC Infectious Disease Diagnostic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioM?rieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
Market Segmentation (by Type)
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the OTC and DTC Infectious Disease Diagnostic Market
Overview of the regional outlook of the OTC and DTC Infectious Disease Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the OTC and DTC Infectious Disease Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of OTC and DTC Infectious Disease Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global OTC and DTC Infectious Disease Diagnostic market size was estimated at USD 5438.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global OTC and DTC Infectious Disease Diagnostic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global OTC and DTC Infectious Disease Diagnostic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the OTC and DTC Infectious Disease Diagnostic market.
Global OTC and DTC Infectious Disease Diagnostic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioM?rieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
Market Segmentation (by Type)
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the OTC and DTC Infectious Disease Diagnostic Market
Overview of the regional outlook of the OTC and DTC Infectious Disease Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the OTC and DTC Infectious Disease Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of OTC and DTC Infectious Disease Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of OTC and DTC Infectious Disease Diagnostic
1.2 Key Market Segments
1.2.1 OTC and DTC Infectious Disease Diagnostic Segment by Type
1.2.2 OTC and DTC Infectious Disease Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global OTC and DTC Infectious Disease Diagnostic Product Life Cycle
3.3 Global OTC and DTC Infectious Disease Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global OTC and DTC Infectious Disease Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 OTC and DTC Infectious Disease Diagnostic Market Competitive Situation and Trends
3.8.1 OTC and DTC Infectious Disease Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest OTC and DTC Infectious Disease Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 OTC and DTC Infectious Disease Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global OTC and DTC Infectious Disease Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to OTC and DTC Infectious Disease Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (2020-2025)
6.4 Global OTC and DTC Infectious Disease Diagnostic Price by Type (2020-2025)
7 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global OTC and DTC Infectious Disease Diagnostic Market Sales by Application (2020-2025)
7.3 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
8 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SALES BY REGION
8.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region
8.2 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.3 North America
8.3.1 North America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.3.2 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe OTC and DTC Infectious Disease Diagnostic Sales by Country
8.4.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region
8.5.2 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.6.2 South America OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region
8.7.2 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of OTC and DTC Infectious Disease Diagnostic by Region(2020-2025)
9.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America OTC and DTC Infectious Disease Diagnostic Production
9.4.1 North America OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe OTC and DTC Infectious Disease Diagnostic Production
9.5.1 Europe OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan OTC and DTC Infectious Disease Diagnostic Production (2020-2025)
9.6.1 Japan OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China OTC and DTC Infectious Disease Diagnostic Production (2020-2025)
9.7.1 China OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.7.2 China OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
10.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Bio-Rad Laboratories Inc
10.2.1 Bio-Rad Laboratories Inc Basic Information
10.2.2 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
10.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.2.4 Bio-Rad Laboratories Inc Business Overview
10.2.5 Bio-Rad Laboratories Inc SWOT Analysis
10.2.6 Bio-Rad Laboratories Inc Recent Developments
10.3 BD
10.3.1 BD Basic Information
10.3.2 BD OTC and DTC Infectious Disease Diagnostic Product Overview
10.3.3 BD OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.3.4 BD Business Overview
10.3.5 BD SWOT Analysis
10.3.6 BD Recent Developments
10.4 Bosch Healthcare Solutions GmbH
10.4.1 Bosch Healthcare Solutions GmbH Basic Information
10.4.2 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.4.4 Bosch Healthcare Solutions GmbH Business Overview
10.4.5 Bosch Healthcare Solutions GmbH Recent Developments
10.5 Danaher
10.5.1 Danaher Basic Information
10.5.2 Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
10.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.5.4 Danaher Business Overview
10.5.5 Danaher Recent Developments
10.6 ThermoFisher Scientific
10.6.1 ThermoFisher Scientific Basic Information
10.6.2 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
10.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.6.4 ThermoFisher Scientific Business Overview
10.6.5 ThermoFisher Scientific Recent Developments
10.7 Siemens AG
10.7.1 Siemens AG Basic Information
10.7.2 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.7.4 Siemens AG Business Overview
10.7.5 Siemens AG Recent Developments
10.8 Roche Holding AG
10.8.1 Roche Holding AG Basic Information
10.8.2 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.8.4 Roche Holding AG Business Overview
10.8.5 Roche Holding AG Recent Developments
10.9 Hologic, Inc.
10.9.1 Hologic, Inc. Basic Information
10.9.2 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.9.4 Hologic, Inc. Business Overview
10.9.5 Hologic, Inc. Recent Developments
10.10 Qiagen
10.10.1 Qiagen Basic Information
10.10.2 Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
10.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.10.4 Qiagen Business Overview
10.10.5 Qiagen Recent Developments
10.11 Cardinal Health
10.11.1 Cardinal Health Basic Information
10.11.2 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
10.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.11.4 Cardinal Health Business Overview
10.11.5 Cardinal Health Recent Developments
10.12 Quest Diagnostics Incorporated
10.12.1 Quest Diagnostics Incorporated Basic Information
10.12.2 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
10.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.12.4 Quest Diagnostics Incorporated Business Overview
10.12.5 Quest Diagnostics Incorporated Recent Developments
10.13 Ador Diagnostics
10.13.1 Ador Diagnostics Basic Information
10.13.2 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
10.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.13.4 Ador Diagnostics Business Overview
10.13.5 Ador Diagnostics Recent Developments
10.14 Akonni Biosystems, Inc.
10.14.1 Akonni Biosystems, Inc. Basic Information
10.14.2 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.14.4 Akonni Biosystems, Inc. Business Overview
10.14.5 Akonni Biosystems, Inc. Recent Developments
10.15 Alveo Technologies
10.15.1 Alveo Technologies Basic Information
10.15.2 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
10.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.15.4 Alveo Technologies Business Overview
10.15.5 Alveo Technologies Recent Developments
10.16 Binx Health Inc.
10.16.1 Binx Health Inc. Basic Information
10.16.2 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.16.4 Binx Health Inc. Business Overview
10.16.5 Binx Health Inc. Recent Developments
10.17 bioM?rieux, Inc.
10.17.1 bioM?rieux, Inc. Basic Information
10.17.2 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.17.3 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.17.4 bioM?rieux, Inc. Business Overview
10.17.5 bioM?rieux, Inc. Recent Developments
10.18 Curetis
10.18.1 Curetis Basic Information
10.18.2 Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
10.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.18.4 Curetis Business Overview
10.18.5 Curetis Recent Developments
10.19 Sysmex Europe GmbH
10.19.1 Sysmex Europe GmbH Basic Information
10.19.2 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.19.4 Sysmex Europe GmbH Business Overview
10.19.5 Sysmex Europe GmbH Recent Developments
10.20 Diasorin S.p.A
10.20.1 Diasorin S.p.A Basic Information
10.20.2 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
10.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.20.4 Diasorin S.p.A Business Overview
10.20.5 Diasorin S.p.A Recent Developments
11 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast
11.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region
11.2.4 South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of OTC and DTC Infectious Disease Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of OTC and DTC Infectious Disease Diagnostic by Type (2026-2035)
12.1.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of OTC and DTC Infectious Disease Diagnostic by Type (2026-2035)
12.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Application (2026-2035)
12.2.1 Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of OTC and DTC Infectious Disease Diagnostic
1.2 Key Market Segments
1.2.1 OTC and DTC Infectious Disease Diagnostic Segment by Type
1.2.2 OTC and DTC Infectious Disease Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global OTC and DTC Infectious Disease Diagnostic Product Life Cycle
3.3 Global OTC and DTC Infectious Disease Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global OTC and DTC Infectious Disease Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 OTC and DTC Infectious Disease Diagnostic Market Competitive Situation and Trends
3.8.1 OTC and DTC Infectious Disease Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest OTC and DTC Infectious Disease Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 OTC and DTC Infectious Disease Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global OTC and DTC Infectious Disease Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to OTC and DTC Infectious Disease Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (2020-2025)
6.4 Global OTC and DTC Infectious Disease Diagnostic Price by Type (2020-2025)
7 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global OTC and DTC Infectious Disease Diagnostic Market Sales by Application (2020-2025)
7.3 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
8 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET SALES BY REGION
8.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region
8.2 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.3 North America
8.3.1 North America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.3.2 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe OTC and DTC Infectious Disease Diagnostic Sales by Country
8.4.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region
8.5.2 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.6.2 South America OTC and DTC Infectious Disease Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region
8.7.2 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of OTC and DTC Infectious Disease Diagnostic by Region(2020-2025)
9.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America OTC and DTC Infectious Disease Diagnostic Production
9.4.1 North America OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe OTC and DTC Infectious Disease Diagnostic Production
9.5.1 Europe OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan OTC and DTC Infectious Disease Diagnostic Production (2020-2025)
9.6.1 Japan OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China OTC and DTC Infectious Disease Diagnostic Production (2020-2025)
9.7.1 China OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2020-2025)
9.7.2 China OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
10.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Bio-Rad Laboratories Inc
10.2.1 Bio-Rad Laboratories Inc Basic Information
10.2.2 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
10.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.2.4 Bio-Rad Laboratories Inc Business Overview
10.2.5 Bio-Rad Laboratories Inc SWOT Analysis
10.2.6 Bio-Rad Laboratories Inc Recent Developments
10.3 BD
10.3.1 BD Basic Information
10.3.2 BD OTC and DTC Infectious Disease Diagnostic Product Overview
10.3.3 BD OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.3.4 BD Business Overview
10.3.5 BD SWOT Analysis
10.3.6 BD Recent Developments
10.4 Bosch Healthcare Solutions GmbH
10.4.1 Bosch Healthcare Solutions GmbH Basic Information
10.4.2 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.4.4 Bosch Healthcare Solutions GmbH Business Overview
10.4.5 Bosch Healthcare Solutions GmbH Recent Developments
10.5 Danaher
10.5.1 Danaher Basic Information
10.5.2 Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
10.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.5.4 Danaher Business Overview
10.5.5 Danaher Recent Developments
10.6 ThermoFisher Scientific
10.6.1 ThermoFisher Scientific Basic Information
10.6.2 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
10.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.6.4 ThermoFisher Scientific Business Overview
10.6.5 ThermoFisher Scientific Recent Developments
10.7 Siemens AG
10.7.1 Siemens AG Basic Information
10.7.2 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.7.4 Siemens AG Business Overview
10.7.5 Siemens AG Recent Developments
10.8 Roche Holding AG
10.8.1 Roche Holding AG Basic Information
10.8.2 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.8.4 Roche Holding AG Business Overview
10.8.5 Roche Holding AG Recent Developments
10.9 Hologic, Inc.
10.9.1 Hologic, Inc. Basic Information
10.9.2 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.9.4 Hologic, Inc. Business Overview
10.9.5 Hologic, Inc. Recent Developments
10.10 Qiagen
10.10.1 Qiagen Basic Information
10.10.2 Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
10.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.10.4 Qiagen Business Overview
10.10.5 Qiagen Recent Developments
10.11 Cardinal Health
10.11.1 Cardinal Health Basic Information
10.11.2 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
10.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.11.4 Cardinal Health Business Overview
10.11.5 Cardinal Health Recent Developments
10.12 Quest Diagnostics Incorporated
10.12.1 Quest Diagnostics Incorporated Basic Information
10.12.2 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
10.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.12.4 Quest Diagnostics Incorporated Business Overview
10.12.5 Quest Diagnostics Incorporated Recent Developments
10.13 Ador Diagnostics
10.13.1 Ador Diagnostics Basic Information
10.13.2 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
10.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.13.4 Ador Diagnostics Business Overview
10.13.5 Ador Diagnostics Recent Developments
10.14 Akonni Biosystems, Inc.
10.14.1 Akonni Biosystems, Inc. Basic Information
10.14.2 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.14.4 Akonni Biosystems, Inc. Business Overview
10.14.5 Akonni Biosystems, Inc. Recent Developments
10.15 Alveo Technologies
10.15.1 Alveo Technologies Basic Information
10.15.2 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
10.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.15.4 Alveo Technologies Business Overview
10.15.5 Alveo Technologies Recent Developments
10.16 Binx Health Inc.
10.16.1 Binx Health Inc. Basic Information
10.16.2 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.16.4 Binx Health Inc. Business Overview
10.16.5 Binx Health Inc. Recent Developments
10.17 bioM?rieux, Inc.
10.17.1 bioM?rieux, Inc. Basic Information
10.17.2 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.17.3 bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.17.4 bioM?rieux, Inc. Business Overview
10.17.5 bioM?rieux, Inc. Recent Developments
10.18 Curetis
10.18.1 Curetis Basic Information
10.18.2 Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
10.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.18.4 Curetis Business Overview
10.18.5 Curetis Recent Developments
10.19 Sysmex Europe GmbH
10.19.1 Sysmex Europe GmbH Basic Information
10.19.2 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.19.4 Sysmex Europe GmbH Business Overview
10.19.5 Sysmex Europe GmbH Recent Developments
10.20 Diasorin S.p.A
10.20.1 Diasorin S.p.A Basic Information
10.20.2 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
10.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.20.4 Diasorin S.p.A Business Overview
10.20.5 Diasorin S.p.A Recent Developments
11 OTC AND DTC INFECTIOUS DISEASE DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast
11.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region
11.2.4 South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of OTC and DTC Infectious Disease Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of OTC and DTC Infectious Disease Diagnostic by Type (2026-2035)
12.1.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of OTC and DTC Infectious Disease Diagnostic by Type (2026-2035)
12.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Application (2026-2035)
12.2.1 Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (M USD)
Table 4. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application
Table 5. OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Region (M USD)
Table 6. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global OTC and DTC Infectious Disease Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2025)
Table 11. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global OTC and DTC Infectious Disease Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. OTC and DTC Infectious Disease Diagnostic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global OTC and DTC Infectious Disease Diagnostic Sales by Type (K Units)
Table 27. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (M USD)
Table 28. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Type (2020-2025)
Table 29. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2020-2025)
Table 30. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Type (2020-2025)
Table 31. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type (2020-2025)
Table 32. Global OTC and DTC Infectious Disease Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 33. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Application
Table 34. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application
Table 35. Global OTC and DTC Infectious Disease Diagnostic Sales by Application (2020-2025) & (K Units)
Table 36. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2020-2025)
Table 37. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 38. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2020-2025)
Table 39. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Table 40. Global OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 41. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2020-2025)
Table 42. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 43. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025)
Table 44. North America OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 45. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 50. South America OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. South America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 54. Global OTC and DTC Infectious Disease Diagnostic Production (K Units) by Region(2020-2025)
Table 55. Global OTC and DTC Infectious Disease Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2020-2025)
Table 57. Global OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
Table 64. Abbott OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Bio-Rad Laboratories Inc Basic Information
Table 69. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
Table 70. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bio-Rad Laboratories Inc Business Overview
Table 72. Bio-Rad Laboratories Inc SWOT Analysis
Table 73. Bio-Rad Laboratories Inc Recent Developments
Table 74. BD Basic Information
Table 75. BD OTC and DTC Infectious Disease Diagnostic Product Overview
Table 76. BD OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. BD Business Overview
Table 78. BD SWOT Analysis
Table 79. BD Recent Developments
Table 80. Bosch Healthcare Solutions GmbH Basic Information
Table 81. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 82. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bosch Healthcare Solutions GmbH Business Overview
Table 84. Bosch Healthcare Solutions GmbH Recent Developments
Table 85. Danaher Basic Information
Table 86. Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
Table 87. Danaher OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Danaher Business Overview
Table 89. Danaher Recent Developments
Table 90. ThermoFisher Scientific Basic Information
Table 91. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
Table 92. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ThermoFisher Scientific Business Overview
Table 94. ThermoFisher Scientific Recent Developments
Table 95. Siemens AG Basic Information
Table 96. Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 97. Siemens AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Siemens AG Business Overview
Table 99. Siemens AG Recent Developments
Table 100. Roche Holding AG Basic Information
Table 101. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 102. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Roche Holding AG Business Overview
Table 104. Roche Holding AG Recent Developments
Table 105. Hologic, Inc. Basic Information
Table 106. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 107. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hologic, Inc. Business Overview
Table 109. Hologic, Inc. Recent Developments
Table 110. Qiagen Basic Information
Table 111. Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
Table 112. Qiagen OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Qiagen Business Overview
Table 114. Qiagen Recent Developments
Table 115. Cardinal Health Basic Information
Table 116. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
Table 117. Cardinal Health OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Cardinal Health Business Overview
Table 119. Cardinal Health Recent Developments
Table 120. Quest Diagnostics Incorporated Basic Information
Table 121. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
Table 122. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Quest Diagnostics Incorporated Business Overview
Table 124. Quest Diagnostics Incorporated Recent Developments
Table 125. Ador Diagnostics Basic Information
Table 126. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
Table 127. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ador Diagnostics Business Overview
Table 129. Ador Diagnostics Recent Developments
Table 130. Akonni Biosystems, Inc. Basic Information
Table 131. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 132. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Akonni Biosystems, Inc. Business Overview
Table 134. Akonni Biosystems, Inc. Recent Developments
Table 135. Alveo Technologies Basic Information
Table 136. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
Table 137. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Alveo Technologies Business Overview
Table 139. Alveo Technologies Recent Developments
Table 140. Binx Health Inc. Basic Information
Table 141. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 142. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Binx Health Inc. Business Overview
Table 144. Binx Health Inc. Recent Developments
Table 145. bioM?rieux, Inc. Basic Information
Table 146. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 147. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. bioM?rieux, Inc. Business Overview
Table 149. bioM?rieux, Inc. Recent Developments
Table 150. Curetis Basic Information
Table 151. Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
Table 152. Curetis OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Curetis Business Overview
Table 154. Curetis Recent Developments
Table 155. Sysmex Europe GmbH Basic Information
Table 156. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 157. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sysmex Europe GmbH Business Overview
Table 159. Sysmex Europe GmbH Recent Developments
Table 160. Diasorin S.p.A Basic Information
Table 161. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
Table 162. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Diasorin S.p.A Business Overview
Table 164. Diasorin S.p.A Recent Developments
Table 165. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global OTC and DTC Infectious Disease Diagnostic Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (M USD)
Table 4. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application
Table 5. OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Region (M USD)
Table 6. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global OTC and DTC Infectious Disease Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2025)
Table 11. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global OTC and DTC Infectious Disease Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. OTC and DTC Infectious Disease Diagnostic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global OTC and DTC Infectious Disease Diagnostic Sales by Type (K Units)
Table 27. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (M USD)
Table 28. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Type (2020-2025)
Table 29. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2020-2025)
Table 30. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Type (2020-2025)
Table 31. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type (2020-2025)
Table 32. Global OTC and DTC Infectious Disease Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 33. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Application
Table 34. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application
Table 35. Global OTC and DTC Infectious Disease Diagnostic Sales by Application (2020-2025) & (K Units)
Table 36. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2020-2025)
Table 37. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 38. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2020-2025)
Table 39. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Table 40. Global OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 41. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2020-2025)
Table 42. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 43. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025)
Table 44. North America OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 45. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 50. South America OTC and DTC Infectious Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. South America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 54. Global OTC and DTC Infectious Disease Diagnostic Production (K Units) by Region(2020-2025)
Table 55. Global OTC and DTC Infectious Disease Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2020-2025)
Table 57. Global OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
Table 64. Abbott OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Bio-Rad Laboratories Inc Basic Information
Table 69. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
Table 70. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bio-Rad Laboratories Inc Business Overview
Table 72. Bio-Rad Laboratories Inc SWOT Analysis
Table 73. Bio-Rad Laboratories Inc Recent Developments
Table 74. BD Basic Information
Table 75. BD OTC and DTC Infectious Disease Diagnostic Product Overview
Table 76. BD OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. BD Business Overview
Table 78. BD SWOT Analysis
Table 79. BD Recent Developments
Table 80. Bosch Healthcare Solutions GmbH Basic Information
Table 81. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 82. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bosch Healthcare Solutions GmbH Business Overview
Table 84. Bosch Healthcare Solutions GmbH Recent Developments
Table 85. Danaher Basic Information
Table 86. Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
Table 87. Danaher OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Danaher Business Overview
Table 89. Danaher Recent Developments
Table 90. ThermoFisher Scientific Basic Information
Table 91. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
Table 92. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ThermoFisher Scientific Business Overview
Table 94. ThermoFisher Scientific Recent Developments
Table 95. Siemens AG Basic Information
Table 96. Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 97. Siemens AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Siemens AG Business Overview
Table 99. Siemens AG Recent Developments
Table 100. Roche Holding AG Basic Information
Table 101. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 102. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Roche Holding AG Business Overview
Table 104. Roche Holding AG Recent Developments
Table 105. Hologic, Inc. Basic Information
Table 106. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 107. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hologic, Inc. Business Overview
Table 109. Hologic, Inc. Recent Developments
Table 110. Qiagen Basic Information
Table 111. Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
Table 112. Qiagen OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Qiagen Business Overview
Table 114. Qiagen Recent Developments
Table 115. Cardinal Health Basic Information
Table 116. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
Table 117. Cardinal Health OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Cardinal Health Business Overview
Table 119. Cardinal Health Recent Developments
Table 120. Quest Diagnostics Incorporated Basic Information
Table 121. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
Table 122. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Quest Diagnostics Incorporated Business Overview
Table 124. Quest Diagnostics Incorporated Recent Developments
Table 125. Ador Diagnostics Basic Information
Table 126. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
Table 127. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ador Diagnostics Business Overview
Table 129. Ador Diagnostics Recent Developments
Table 130. Akonni Biosystems, Inc. Basic Information
Table 131. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 132. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Akonni Biosystems, Inc. Business Overview
Table 134. Akonni Biosystems, Inc. Recent Developments
Table 135. Alveo Technologies Basic Information
Table 136. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
Table 137. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Alveo Technologies Business Overview
Table 139. Alveo Technologies Recent Developments
Table 140. Binx Health Inc. Basic Information
Table 141. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 142. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Binx Health Inc. Business Overview
Table 144. Binx Health Inc. Recent Developments
Table 145. bioM?rieux, Inc. Basic Information
Table 146. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 147. bioM?rieux, Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. bioM?rieux, Inc. Business Overview
Table 149. bioM?rieux, Inc. Recent Developments
Table 150. Curetis Basic Information
Table 151. Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
Table 152. Curetis OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Curetis Business Overview
Table 154. Curetis Recent Developments
Table 155. Sysmex Europe GmbH Basic Information
Table 156. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 157. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sysmex Europe GmbH Business Overview
Table 159. Sysmex Europe GmbH Recent Developments
Table 160. Diasorin S.p.A Basic Information
Table 161. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
Table 162. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Diasorin S.p.A Business Overview
Table 164. Diasorin S.p.A Recent Developments
Table 165. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global OTC and DTC Infectious Disease Diagnostic Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of OTC and DTC Infectious Disease Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD), 2025-2035
Figure 5. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) (2020-2035)
Figure 6. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. OTC and DTC Infectious Disease Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global OTC and DTC Infectious Disease Diagnostic Product Life Cycle
Figure 13. OTC and DTC Infectious Disease Diagnostic Sales Share by Manufacturers in 2025
Figure 14. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers in 2025
Figure 15. OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by OTC and DTC Infectious Disease Diagnostic Revenue in 2025
Figure 18. Industry Chain Map of OTC and DTC Infectious Disease Diagnostic
Figure 19. Global OTC and DTC Infectious Disease Diagnostic Market PEST Analysis
Figure 20. Global OTC and DTC Infectious Disease Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type
Figure 27. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2025
Figure 29. Market Share of OTC and DTC Infectious Disease Diagnostic by Type (2020-2025)
Figure 30. Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application
Figure 33. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application in 2025
Figure 35. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2020-2025)
Figure 36. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application in 2025
Figure 37. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025)
Figure 40. North America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 43. North America OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 45. U.S. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada OTC and DTC Infectious Disease Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada OTC and DTC Infectious Disease Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico OTC and DTC Infectious Disease Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico OTC and DTC Infectious Disease Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 55. Germany OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region in 2024
Figure 68. China OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 80. South America OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 82. Brazil OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region in 2024
Figure 92. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global OTC and DTC Infectious Disease Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Type (2026-2035)
Figure 111. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Application (2026-2035)
Figure 112. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of OTC and DTC Infectious Disease Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD), 2025-2035
Figure 5. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) (2020-2035)
Figure 6. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. OTC and DTC Infectious Disease Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global OTC and DTC Infectious Disease Diagnostic Product Life Cycle
Figure 13. OTC and DTC Infectious Disease Diagnostic Sales Share by Manufacturers in 2025
Figure 14. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers in 2025
Figure 15. OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by OTC and DTC Infectious Disease Diagnostic Revenue in 2025
Figure 18. Industry Chain Map of OTC and DTC Infectious Disease Diagnostic
Figure 19. Global OTC and DTC Infectious Disease Diagnostic Market PEST Analysis
Figure 20. Global OTC and DTC Infectious Disease Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type
Figure 27. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2025
Figure 29. Market Share of OTC and DTC Infectious Disease Diagnostic by Type (2020-2025)
Figure 30. Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application
Figure 33. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application in 2025
Figure 35. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2020-2025)
Figure 36. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application in 2025
Figure 37. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025)
Figure 40. North America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 43. North America OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 45. U.S. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada OTC and DTC Infectious Disease Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada OTC and DTC Infectious Disease Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico OTC and DTC Infectious Disease Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico OTC and DTC Infectious Disease Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 55. Germany OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region in 2024
Figure 68. China OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2024
Figure 80. South America OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America OTC and DTC Infectious Disease Diagnostic Market Size by Country in 2024
Figure 82. Brazil OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size by Region in 2024
Figure 92. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa OTC and DTC Infectious Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global OTC and DTC Infectious Disease Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Type (2026-2035)
Figure 111. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Application (2026-2035)
Figure 112. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Application (2026-2035)
